Pediatr. praxi. 2015;16(4):224-226

Anaphylaxis in children - a practial recommendation

doc.MUDr.Vít Petrů, CSc.
Centrum alergologie a klinické imunologie, Nemocnice Na Homolce, Praha

Anaphylaxis is an acute, potentially life-threatening syndrome with multisystemic manifestations due to the rapid release of proinflammatory

mediators. In children, foods can be a significant trigger for anaphylaxis (milk, eggs, wheat, soy, peanuts, fish and others). Patients

experiencing anaphylaxis can present with cutaneous, respiratory, cardiovascular or gastrointestinal manifestations. Epinephrine given

intramusculary remains the mainstay of treatment for this condition. Other second or third-line therapies, such as inhaled beta-2 agonists,

H1 and H2 receptor antagonists and corticosteroids, may play a role in resolving respiratory and cutaneous signs and symptoms. Biphasic

reactions may occur during the resolution phase of symptoms and, thus, all patients should be observed before discharge from hospital.

On discharge, all patients should be prescribed epinephrine autoinjectors, and referred to an allergist for further evaluation and education.

Keywords: anaphylaxis, epinephrine

Published: September 20, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Petrů V. Anaphylaxis in children - a practial recommendation. Pediatr. praxi. 2015;16(4):224-226.
Download citation

References

  1. Simons FER. Anaphylaxis. In: Global atlas of Allergy, EAACI 2014.
  2. Turner PJ, Gowland MH, Sharma V, et al. Increase in anaphylaxis-related hospitalizations but no increase in fatalities: An analysis of United Kingdom national anaphylaxis data, 1992-2012. J Allergy Clin Immunol, 2015; 135: 956-963. Go to original source... Go to PubMed...
  3. Petrů V, a kol. Anafylaxe. In. Dětská alergologie, Mladá fronta, 2012.
  4. Petrů V, Krčmová I. Anafylaktická reakce. Farmakoterapie pro praxi. Jesenius Maxdorf, 2006
  5. Muraro A, Roberts G, Worm M et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Position paper. Allergy 2014; 69: 1026-1045. Go to original source... Go to PubMed...
  6. Petrů V. Adrenalin - lék první volby v léčbě anafylaxe. Alergie 2009; 11: 39-43.
  7. Fleming JF, Clark S, Camargo CA, et al. Early treatment of food-induced anaphylaxis with epinephrine is associated with low risk of hospitalization. J Allergy Clin Immunol Pract 2015; 3: 57-67. Go to original source... Go to PubMed...
  8. Simons FER, Roberts JR, Gu X, et al. Epinephrine absorption in children with a history of anaphylaxis. J Allergy Clin Immunol 1998; 106: 1040-1044. Go to original source... Go to PubMed...
  9. Campbell RL, Bellolio MF, Knutson BD, et al. Epinephrine in anaphylaxis: Higher risk of cardiovascular complication and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine. J Allergy Clin Immunol Pract 2015; 3: 76-80. Go to original source... Go to PubMed...
  10. Simons FER, Chan ES, Gu X, et al. Epinephrine for the out-of-hospital (first aid) treatment of anaphylaxis in infants: is the ampule/syringe/needle method practical?. J Allergy Clin Immunol 2001; 106: 1040-1044. Go to original source... Go to PubMed...
  11. Lieberman P. The 10-second rule and other myths about epinephrine and autoinjectors. Ann Allergy Asthma Immunol 2011; 107: 189-190. Go to original source... Go to PubMed...
  12. Baker TW. The TEN study: time epinephrine needs to reach muscle. Ann Allergy Asthma Immunol 2011; 107: 235-238. Go to original source... Go to PubMed...
  13. Rachid O, Simons FRE, Rawa-Qalaji M, et al. Epinephrine autoinjectors: Does freezing or refrigeration affect epinephrine dose delivery and enanciomeric purity? J. Allergy Clin Immunol Pract 2015; 3: 294-296. Go to original source... Go to PubMed...
  14. Solařová V. Informace pro potravinové alergiky, 2015, Alergocentrum Šumperk, v tisku.




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.